S 15535, A Novel Benzodioxopiperazine Ligand of Serotonin (5-HT)1A Receptors: II. Modulation of Hippocampal Serotonin Release in Relation to Potential Anxiolytic Properties

Mark J. Millan; Stephan Hjorth; Rosario Samanin; Rudy Schreiber; Robert Jaffard; Brigitte De Ladonchamps; Sylvie Veiga; Bertrand Goument; Jean-Louis Peglion; Michael Spedding; Mauricette Brocco

OtherNEUROPHARMACOLOGY

S 15535, A Novel Benzodioxopiperazine Ligand of Serotonin (5-HT)_1A Receptors: II. Modulation of Hippocampal Serotonin Release in Relation to Potential Anxiolytic Properties

Mark J. Millan, Stephan Hjorth, Rosario Samanin, Rudy Schreiber, Robert Jaffard, Brigitte De Ladonchamps, Sylvie Veiga, Bertrand Goument, Jean-Louis Peglion, Michael Spedding and Mauricette Brocco

Journal of Pharmacology and Experimental Therapeutics July 1997, 282 (1) 148-161;

Mark J. Millan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Stephan Hjorth

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rosario Samanin

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rudy Schreiber

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robert Jaffard

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Brigitte De Ladonchamps

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sylvie Veiga

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Bertrand Goument

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jean-Louis Peglion

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael Spedding

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mauricette Brocco

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
eLetters
PDF

Submit a Response to This Article

Compose eLetter

Title *

Contents

More information about text formats

Plain text

No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. higgs-boson@gmail.com Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.

PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics

Vol. 282, Issue 1

1 Jul 1997

Table of Contents
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following S 15535, A Novel Benzodioxopiperazine Ligand of Serotonin (5-HT)1A Receptors: II. Modulation of Hippocampal Serotonin Release in Relation to Potential Anxiolytic Properties

Message Subject (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics

Message Body (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

OtherNEUROPHARMACOLOGY

S 15535, A Novel Benzodioxopiperazine Ligand of Serotonin (5-HT)_1A Receptors: II. Modulation of Hippocampal Serotonin Release in Relation to Potential Anxiolytic Properties

Mark J. Millan, Stephan Hjorth, Rosario Samanin, Rudy Schreiber, Robert Jaffard, Brigitte De Ladonchamps, Sylvie Veiga, Bertrand Goument, Jean-Louis Peglion, Michael Spedding and Mauricette Brocco

Journal of Pharmacology and Experimental Therapeutics July 1, 1997, 282 (1) 148-161;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

OtherNEUROPHARMACOLOGY

S 15535, A Novel Benzodioxopiperazine Ligand of Serotonin (5-HT)_1A Receptors: II. Modulation of Hippocampal Serotonin Release in Relation to Potential Anxiolytic Properties

Mark J. Millan, Stephan Hjorth, Rosario Samanin, Rudy Schreiber, Robert Jaffard, Brigitte De Ladonchamps, Sylvie Veiga, Bertrand Goument, Jean-Louis Peglion, Michael Spedding and Mauricette Brocco

Journal of Pharmacology and Experimental Therapeutics July 1, 1997, 282 (1) 148-161;

Share This Article: